Snake venom phospholipase A2 (PLA2) homolog that shows local myotoxicity, apparent anticoagulant activity (PubMed:15618013), and neurotoxicity (PubMed:17299814). Shows analgesic effect on mice due to a decrease of action potentials and nerve conduction velocity. These effects are caused by inhibition of voltage-gated ion channels (potassium (Kv) and sodium (Nav)) (PubMed:19277489). In addition, analgesic effects are antagonized by naloxone, implying the mechanism of action is correlated with opioid receptors (probably indirectly) (PubMed:17299814). Does not show detectable PLA2 activity on egg yolk phospholipids (PubMed:15618013). Monomer. Expressed by the venom gland. LD(50) is 18.2 mg/kg by intraperitoneal injection into mice. Does not show hemorrhagic activities. Belongs to the phospholipase A2 family. Group II subfamily. Q49 sub-subfamily. Does not bind calcium as one of the calcium-binding sites is lost (Asp->Gln in position 48, which corresponds to 'Gln-49' in the current nomenclature).